Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
You can also connect with us online through chat, our contact form, or the Price Simulator
Outcome Measures The measured outcomes included changes in hepatic steatosis severity, liver enzyme levels (aspartate transaminase [AST] and alanine transaminase [ALT]), serum lipid profile (triglycerides [TG], total cholesterol [TC], low-density lipoprotein cholesterol [LDL-C], and high-density lipoprotein cholesterol [HDL-C]), glycemic markers (fasting blood glucose [FBG], fasting insulin levels, and insulin resistance assessed via the homeostatic model assessment for insulin resistance [HOMA-IR]), oxidative stress markers (glutathione, malondialdehyde [MDA], and total antioxidant capacity [TAC]), and the inflammatory marker C-reactive protein [CRP]
A network-based study reveals multimorbidity patterns in people with type 2 diabetes
PLoS ONE 12 , e0168234 (2017)
US$ 28.11
US$ 24.92
US$ 28.36
US$ 27.32
US$ 24.99
